What you're getting is a dual agonist targeting both GLP-1 and GIP receptors — that dual mechanism basically outperforms single-target peptides for metabolic research, and our company can dial in custom vial sizes or concentrations if your protocol calls for something outside the standdard 20mg per vial.
CAS hits at 2023788-19-2 with a molecular weight around 4813 g/mol, purity verified by HPLC at 99% or better, and it's a white to off-white powder soluble in water so reconstitution is straightforward at typical lab volumes.
Most buyers go with this for metabolic syndrome studies where gastric emptying delay and insulin secretion enhancement matter, but it's not really suited for acute dosing work outside controlled protocols — the dual signaling requires careful timing.

Storage needs to be at -20°C and protected form light; one thing you wouldn't think to ask is that even brief exposure to room temperture can degrade potency after about 20 minutes or so (usually 2-4 weeks of stability data is what our company have).
Also, we can do custom labeling and bulk synthesis if your team runs high-throughput screenings, though the 10 format (roughly 50 mg total) is typical for smaller batches.
We usually have stock on hand, but confirm lead time for custom concentrations — a 5 mg per vial option is tighter tolerance than most off-the-shelf sources, so we typically see about 10-15 days for that.